About Legend Capital
Legend Capital is a venture capital firm founded in 2001. It is primarily based out of Haidian, China. As of Apr 2026, Legend Capital is an active investor, having invested in 475 companies, with 13 new investments in the last 12 months. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to Consumer and High Tech. Most recently it participated in the $***** Seed round of Nova Fusion Overall, Legend Capital portfolio has seen 11 unicorns, 61 IPOs and 21 acquisitions including key companies like DiDi, Bilibili and WuXi AppTec. A lot of funds co-invest with Legend Capital, with names like DCM Ventures sharing a substantial percentage of its portfolio. Legend Capital has team of 41 people including 23 partners.Key Metrics
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 8 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Legend Capital's List of Top Investments
Legend Capital has a portfolio of 475 companies, including 11 unicorns. Their most notable investments are in Gambol Pet Group and Photonic Bridges.Their portfolio spans across China, United States, South Korea and 10 more locations. They have invested in Life Sciences, Consumer, High Tech and 38 other sectors, across stages such as Series A, Series B and 8 more. Here is the list of top investments by Legend Capital:
1. DiDi
AI-enabled platform for ride-hailing and on-demand services. The platform enables various services for ride-hailing, food delivery, bike-sharing, payment solutions, and more. It also offers various solutions including autonomous driving, traffic management, driver safety management, and more.
Key facts about DiDi
- Founded Year: 2012
- Location: Beijing (China)
- Stage: Public
- Total Funding till date: $20.8B
- Employee Count: 32,242 as on Mar 31, 2026
- Investors: Silver Lake, Syren Capital Advisors and 97 Others
- Latest Funding Round: Post IPO, Oct 12, 2023, $*****
- Highlight: Public
2. Bilibili
Online video streaming platform for anime. It is themed around anime, manga, and game fandom. Users can submit, view, and add commentary subtitles on videos. The application is available for Android and iOS users. It monetizes through webpage advertisement and affiliate marketing.
Key facts about Bilibili
- Founded Year: 2010
- Location: Yangpu (China)
- Stage: Public
- Employee Count: 2,490 as on Jan 03, 2026
- Investors: Cornerstone Capital, SoftBank Group and 16 Others
- Latest Funding Round: Post IPO, May 21, 2025, $*****
- Highlight: Public
3. WuXi AppTec
WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of $5.84B and a net profit of $1.31B.
Key facts about WuXi AppTec
- Founded Year: 2000
- Location: Shanghai (China)
- Annual Revenue: £7.42M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $40M
- Employee Count: 4,155 as on Nov 16, 2025
- Investors: Strait Huifu Industrial Investment Fund Management, HPR Capital and 27 Others
- Latest Funding Round: Post IPO, Apr 02, 2021, $*****
- Highlight: Public
4. Pharmaron
Pharmaron offers a suite of drug discovery and development services for small molecules, nucleosides, nucleotides, peptides, lipids and carbohydrates. They offer their R&D services across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical and formulation development. The company claims that their chemistry division is one of the largest chemistry service providers in the world with experience and expertise in organic synthesis, library/high-throughput synthesis, chiral chemistry, medicinal, computational and cheminformatics, bioorganic chemistry, process and scale-up, analytical and purification. Their biologics division offers services such as antibody/protein engineering, antibody humanization, cell line development, recombinant antibody production, protein expression, purification, and characterization.The company has acquired Xceleron and SNBL CPC to augment its offerings.
Key facts about Pharmaron
- Founded Year: 2003
- Location: Beijing (China)
- Stage: Public
- Total Funding till date: $320M
- Employee Count: 476 as on Dec 31, 2021
- Investors: Aisling Capital, VMS Asset Management and 11 Others
- Latest Funding Round: PE, Dec 14, 2015, $*****
- Highlight: Public
_1583838062930.png?format=webp&height=120&width=120){kind=logo}
5. GrubMarket
Provider of business to business eCommerce and enterprise AI solutions. The company offers an eCommerce platform providing access to food products. It also provides software solutions covering inventory, warehouse management, grower accounting, human resources, eCommerce, payments, and mobile applications. The company’s enterprise AI solutions offer insights, analysis, voice-powered assistance, and automated order extraction.
Key facts about GrubMarket
- Founded Year: 2014
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series H
- Total Funding till date: $908M
- Employee Count: 117 as on Mar 31, 2026
- Investors: Millennium Technology Value Partners, BlackRock and 98 Others
- Latest Funding Round: Series H, Feb 02, 2026, $*****
- Highlight: Editors' Pick
Legend Capital's Year-on-Year Investment Trends
Legend Capital has invested in 477 companies over the last 23 years, with an average of 22 new investments annually in the last 10 years. In 2025, it made 15 investments, while as of Apr 2026, it has made 6 investments in this year. Its most recent first time investment was in VITURE and most recent follow-on round was in Nova Fusion.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 4 | 6 |
2025 | 11 | 4 | 15 |
2024 | 6 | 4 | 10 |
2023 | 17 | 7 | 24 |
2022 | 49 | 12 | 61 |
2021 | 24 | 16 | 40 |
2020 | 26 | 16 | 42 |
2019 | 22 | 10 | 32 |
2018 | 25 | 23 | 48 |
2017 | 22 | 8 | 30 |
Legend Capital's Investments by Stage
Legend Capital has made 128 investments in Series A stage with an average round size of $29.1M, 108 investments in Series B stage with an average round size of $49.9M and 41 investments in Series C stage with an average round size of $132M.Stage of entry | No. of Investments |
|---|---|
Series A | 128 |
Series B | 108 |
Series C | 41 |
Seed | 31 |
Series D | 8 |
Others | 15 |
Note: We have considered here, only first round of investments
Legend Capital's Investments by Sector
Legend Capital has a diverse portfolio, with companies operating in the Consumer, Life Sciences, Enterprise Applications, High Tech and Healthcare. Notably, it has invested in 269 Tech companies, 213 Enterprise (B2B) companies, 147 Consumer (B2C) companies and at least 114 companies focusing on Software.Sector | No. of Investments |
|---|---|
Consumer | 67 |
Life Sciences | 55 |
Enterprise Applications | 51 |
High Tech | 47 |
Healthcare | 37 |
Others | 341 |
Note: We have considered here, only first round of investments
Legend Capital's Investments by Geography
Legend Capital has made most investments in China (280), followed by United States where it has made 26 investments.Country | No. of Investments |
|---|---|
China | 280 |
United States | 26 |
South Korea | 6 |
Germany | 3 |
India | 2 |
Others | 8 |
Note: We have considered here, only first round of investments
Legend Capital's recent investments
Legend Capital has made 6 investments in 2026 so far. Nova Fusion and VITURE are the latest among them.Here are the most recent investments by Legend Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 12, 2026 | China | Seed | 1618 | [+1] | |
Feb 26, 2026 | United States | Series B | 1466 | ||
Feb 05, 2026 | United States | Series D | 4788 | [+16] | |
Jan 27, 2026 | China | Series C | 2341 | [+3] | |
Jan 12, 2026 | China | Series A | 3035 | [+5] |
Unicorns in Legend Capital's Portfolio
Legend Capital has 11 unicorns in its portfolio - VectorBuilder, SJ Semiconductor, GrubMarket and others. The most recent unicorn in their portfolio is VectorBuilder. It became a unicorn in 2023.Here is a list of unicorns in Legend Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
65 | Online platform for designing vectors | 2014 | Chicago | Series C | ugzpmfw | ||
55 | Provider of semiconductor manufacturing and packaging services | 2014 | Wuxi | Series D | denuguv | ||
75 | Provider of business to business eCommerce and enterprise AI solutions | 2014 | San Francisco | Series H | bzhadvc | ||
32 | Manufacturer of satellites for communication | 2016 | Haidian | Series D | gedzwqd | ||
47 | Platform offering homework help products for students | 2015 | Beijing | Series E | xataj{g |
IPOs and Publicly Listed companies in Legend Capital's Portfolio
61 of Legend Capital's portfolio companies have become public. Haizhi Technology Group got listed on the Hong Kong Exchanges (HKG), in Feb 2026 at marketcap of $1.43B and Souzhou Ribo Life Science got listed on the Hong Kong Exchanges (HKG) at marketcap of $1.23B.Here are Legend Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 13, 2026 | Mar 02, 2016 | Series C | 4972 | |
Jan 09, 2026 | 2015 | Series A | 4966 | |
Jan 08, 2026 | Sep 2022 | Series B | 1066 | |
Nov 17, 2025 | - | - | 4838 | |
Oct 28, 2025 | Jun 08, 2020 | Series B | 2864 |
_1571215573551.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Acquired companies in Legend Capital's Portfolio
21 companies from Legend Capital's portfolio have been acquired. The most recent acquisition was Lakeshorebio in Nov 2025 by Oceanpine Capital for $*****.Here are Legend Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 21, 2025 | Mar 25, 2022 | Series B | 6916 | |
Jul 25, 2024 | Jul 19, 2013 | Series C | 2203 | |
Feb 10, 2024 | Jun 27, 2014 | Series C | 8196 | |
Jan 08, 2024 | Mar 25, 2014 | Series A | 8085 | |
Sep 06, 2023 | Aug 20, 2018 | Series B | 8773 |
Team profile of Legend Capital
Legend Capital has a team of 41 members including 23 Partners and 7 Principals located in China, United States and 1 more location. Legend Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Legend Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | ||
Partner | China | - | - | |
Partner | - | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | Beijing | - | ||
Partner | Jing an | - | ||
Partner | - | - |
Co-investors of Legend Capital
Over the past 23 years, 1463 investors have co-invested in Legend Capital's portfolio companies. This includes funds and angels.
- Invested before Legend Capital: IDG Capital, Qiming Venture Partners and 388 others have invested in rounds before Legend Capital. There are 9 companies where IDG Capital has invested before Legend Capital and 8 companies where Qiming Venture Partners has invested before Legend Capital.
- Top Co-investors of Legend Capital: 421 investors entered a company along with Legend Capital. These include investors like DCM Ventures (8 companies).
- Invested after Legend Capital: A total of 652 investors have invested in Legend Capital's portfolio after their investments. Top Investors include Tencent (8 companies), CICC (7 companies) and China Internet Investment Fund (6 companies).
Recent News related to Legend Capital
•
Liangyi Wanxiang Completes A Round of 100 Million Yuan FinancingEastmoney•Apr 08, 2026•iFLYTEK, Legend Capital, Shunwei Capital, Legend Capital and 5 others
•
VITURE Raises Another $100M, Surpassing $200M in Six MonthsPR Newswire•Feb 26, 2026•VITURE, Legend Holdings, Bertelsmann, Legend Capital and 1 other
•
China's X Square Robot Tech Secures $143M in Series A++ Funding Led by Alibaba Cloud, Meituan & MoreCaproasia•Jan 13, 2026•X Square Robot, HSG, Legend Star, Alibaba Cloud and 7 others
•
•
Obita Raises Nearly US$30M Across Seed and Pre-A RoundsFinSMEs•Jan 12, 2026•Obita, Mirana, Vision Plus Capital, Legend Capital and 1 other
•
Allink Biotherapeutics Closes $47M Series A Extension for Clinical ProgramsPR Newswire•Dec 16, 2025•Allink Biotherapeutics, Legend Capital, Lapam Capital, Yuanbio Venture Capital and 2 others
•
•
•
Shanghai Clinical Transformation Seed Investment Fund EstablishedPEdaily•Oct 21, 2025•Legend Capital
•
Didi Autonomous Driving Secures 2 Billion RMB in Series D Funding
Pandaily•Oct 11, 2025•Zhongguancun Science City, Guanghua Venture Capital, GAC Group, DiDi and 1 other
